In an ageing population, the incidence of hip fracture has been estimated to double between 1990 and 2025. 1 Hip fractures are a frequent cause of mortality in elderly patients and the 30 day mortality after hip fracture surgery has been estimated to be 10%, whereas 1 yr mortality is 18%. 2 3 These patients are also at increased risk of perioperative cardiac events due to multiple comorbidity. Previous studies have indicated that 35-42% of patients undergoing surgical correction of a fractured neck of femur develop myocardial ischaemia in the perioperative period. 4 5 Apart from myocardial damage and ischaemia, left ventricular myocardial dysfunction is a common comorbidity in the elderly. The prevalence of heart failure is between 10% and 20% in 70-to 80-yr-old persons. 6 The prevalence of heart failure is likely to increase in the future, due to a growing number of patients surviving acute coronary syndromes. 7 B-type natriuretic peptide (BNP) and its prohormone, N-terminal fragment of BNP (NT-proBNP), are primarily produced by ventricular cardiomyocytes and have a vasodilatory and natriuretic function. 8 These cardiac peptides are released from the ventricular myocardium in response to increasing wall tension and filling pressures. Circulating concentrations of BNP and NT-proBNP are thus increased in patients with left ventricular systolic dysfunction and congestive heart failure. 9 10 BNP and NT-proBNP also have a prognostic value in patients with congestive heart failure and acute coronary syndrome. 11 12 Furthermore, recent studies indicate that BNP and NT-proBNP are independent predictors of outcome in noncardiac and cardiac surgical settings. 10 13 -17 The aims of this prospective, observational study were to assess the incidence of elevated preoperative NT-proBNP and to investigate whether an elevated NT-proBNP can predict cardiac outcome in high-risk patients undergoing unscheduled hip surgery.
Methods
After receiving approval from the Regional Research Ethics Committee of Linköping University (Ref: M23-07), informed consent was obtained from the 69 subjects with hip fractures included in this prospective, observational study. These 69 subjects formed a cohort within a larger study that included 211 subjects with ASA physical status classification III or IV undergoing emergency or urgent abdominal, gynaecologic, urologic, reconstructive, or orthopaedic surgery. Results were collected over a 12 month period from a single centre. This larger study focused on myocardial damage and cardiac events in the postoperative period. The subgroup analysis of patients with hip fractures was undertaken since this problem is common in geriatric patients and is associated with a high risk for perioperative complications. The subjects were classified according to the physical status classification of the ASA. In addition, the Revised Cardiac Risk Index Score and the New York Heart Association (NYHA) classification were recorded for each subject. 18 
Preoperative measurements
In all subjects, routine laboratory tests and a 12-lead ECG were obtained before operation. Blood samples for NT-proBNP and troponin I (TnI) were analysed 1 h before surgery using the Stratus w CS Acute Care TM Diagnostic System (Dade International Holding GmBH, Lieberbach, Germany). In the case of elevated TnI levels in the preoperative period, the risk of pursuing surgery was weighed against the risk of conservative management by the attending anaesthetist in consultation with the surgeon and a cardiologist.
Intraoperative recordings
Intraoperative events including hypoxaemia (Sp O 2 ,90% for .5 min), hyper/hypotension (+30% of baseline for .5 min), bradycardia (,50 beats min 21 for .5 min), tachycardia (.30 beats min 21 from baseline for .5 min), new arrhythmia, and intraoperative bleeding were recorded. The choices of pre-and intraoperative fluid management, anaesthetic technique, and perioperative clinical decisions were not controlled by the study protocol, but left to the discretion of the attending anaesthetist. The clinicians were not blinded to the preoperative NT-proBNP or TnI levels.
Postoperative recordings and measurements
TnI was measured 12 and 48 h after operation and the diagnostic threshold for myocardial damage was .0.06 mg litre
21
. In the case of an elevated TnI in the postoperative period, a 12-lead ECG was obtained and the patient was referred to a cardiologist. All ECGs were examined by a cardiologist blinded to TnI values, clinical symptoms, and outcome. ECG signs of myocardial ischaemia were defined as the presence of new Q waves lasting 0.04 s and 1 mm deep or ST segment elevation or depression 1 mm in at least two adjacent leads.
In the perioperative period, adverse cardiac events were recorded, including myocardial damage, acute myocardial infarction, and/or death within 30 days of surgery.
Follow-up
The subjects were interviewed at 30 days and 3 months after operation to determine major adverse events after discharge. Mortality rates (30 days and 3 months) after surgery were obtained through the analysis of medical records and death certificates.
Statistical analysis
For identification of the NT-proBNP cut-off value that best predicted perioperative cardiac events, the receiver operating characteristic (ROC) curve was used and the area under the curve was calculated. The primary endpoint was the incidence of elevated NT-proBNP and its relationship to the cardiac events described earlier. Secondary endpoints were myocardial damage, perioperative adverse cardiac events, and all-cause mortality, 30 days and 3 months after surgery. NT-proBNP was found not to be normally distributed, and therefore, the results are expressed as median and inter-quartile range (IQR). The association between baseline and perioperative characteristics and elevated NT-proBNP was explored using the x 2 test for dichotomous data, unpaired t-test for continuous variables, and the Mann -Whitney U-test for nonparametric variables. Both uni-and multivariate logistic analyses were used to identify clinical variables predictive of perioperative adverse cardiac events. A preoperative elevated TnI was not included in this analysis, since it was included in the definition of adverse cardiac events. Variables with a P-value of ,0.10 were included in a stepwise logistic regression to test the independence of the NT-proBNP predicts cardiac events in hip surgery predictors. The results are presented as unadjusted and adjusted odds ratios (OR) and their 95% confidence interval (CI).
A two-tailed P-value of ,0.05 was considered statistically significant. All analyses were performed using STATA v10.1 (Stata Corp LP, College Station, TX, USA).
Results
All 69 subjects undergoing surgical correction of proximal femur fracture during the study period were included in the analyses. Subject characteristics are summarized in Table 1 .
N-terminal pro-B-type natriuretic peptide
An ROC curve analysis for identification of the NT-proBNP level that best predicted perioperative cardiac events is shown in Figure 1 . An NT-proBNP of 3984 ng litre 21 had a sensitivity of 69% and a specificity of 71% for predicting adverse cardiac events, likelihood ratio 2.27. The area under the ROC curve was 0.78 (95% CI 0.66-0.87).
Thirty-four subjects (49%) had an NT-proBNP 3984 ng litre 21 before surgery. Baseline characteristics of patients with NT-proBNP 3984 and ,3984 ng litre 21 are presented in Table 1 . Subjects with NT-proBNP above the diagnostic threshold had statistically significant lower BMI and higher creatinine levels than those with NT-proBNP below 3984 ng litre 21 . In addition, subjects with NT-proBNP below the cut-off level had a known history of stroke more frequently than those with NT-proBNP above the cut-off level. Table 2 shows the perioperative characteristics of subjects with and without elevated NT-proBNP values. No statistically significant differences between the groups were seen regarding the type of anaesthesia, type of surgery, duration of surgery, or peroperative bleeding. Subjects with elevated NT-proBNP had a higher body temperature in the postoperative care unit than those without NT-proBNP elevation.
Perioperative myocardial damage
The overall incidence of elevated TnI 48 h after surgery was 45%. Twenty-one subjects (62%) with increased levels of NT-proBNP had myocardial damage 48 h after , P,0.01. In addition, 18 of the 31 subjects (58%) with a TnI .0.06 mg litre 21 after operation had a TnI elevation before surgery. Eleven of these subjects (32%) had an NT-proBNP above the diagnostic threshold and seven (20%) had an NT-proBNP below the diagnostic threshold, P¼0.24. In subjects with a preoperative elevated TnI, three subjects were rescheduled and transferred for medical treatment, further investigations, or both. In nine subjects, perioperative monitoring was intensified compared with the standard routines in our department, but surgery was not delayed. Two subjects received a different anaesthetic technique owing to myocardial damage in combination with clinically significant aortic stenosis. In all other cases, surgery was carried out without any alteration in perioperative care.
Cardiac events
Thirty-four subjects (49%) had a perioperative cardiac event within 30 days after surgery. Twenty-two subjects with cardiac events (65%) had NT-proBNP above the diagnostic threshold compared with 12 subjects (34%) without an NT-proBNP elevation, P¼0.01. Tables 1 and 2 show the background and perioperative data of patients with and without perioperative cardiac events. Subjects with cardiac events were significantly older, underwent surgery under regional anaesthesia, and had intraoperative episodes of hypoxaemia more frequently than patients without events. No other baseline or perioperative characteristics significantly correlated with perioperative cardiac events. All pre-and postoperative variables with P0.10 were entered into a univariate logistic regression analysis. Hypoxaemia was not entered due to the fact that all subjects who had a hypoxic episode also had cardiac events. After adjusting for confounding factors, the two remaining independent predictors of adverse cardiac events were preoperative NT-proBNP 3984 ng litre 21 , OR 3.0 (95% CI 1.0-8.9), and congestive heart failure, OR 3.0 (95% CI 1.0-9.0) ( Table 3) .
If subjects with elevated TnI before surgery were excluded, 22 subjects (32%) developed a postoperative cardiac event. Nineteen of these subjects (90%) had an NT-proBNP 3984 ng litre 21 before surgery.
Mortality
Eight subjects (12%) died within 30 days of surgery. Four subjects who died had NT-proBNP 3984 ng litre 21 before surgery and four patients had NT-proBNP below the diagnostic threshold. At 3 months after operation, 13 subjects (19%) had died, 10 with a perioperative cardiac event (29%), compared with three (9%) without a perioperative cardiac event (P¼0.03). No statistically significant difference was seen in the 3 month mortality rate in subjects above and below the diagnostic NT-proBNP threshold.
Discussion
In this prospective observational study on subjects with ASA physical status classification III or IV undergoing non-elective surgery for proximal femur fracture, 34 subjects (49%) had NT-proBNP above the diagnostic threshold before surgery. Twenty-two subjects (65%) with a preoperative elevated NT-proBNP had perioperative adverse cardiac events. An NT-proBNP 3984 ng litre 21 was an independent predictor of adverse cardiac events in the perioperative period.
There are many clinical conditions that can lead to elevated levels of BNP and NT-proBNP, in addition to cardiac failure including myocardial ischaemia, sepsis, pulmonary hypertension, and renal failure. 19 20 Since a large number of conditions are associated with elevated NT-proBNP, we could not verify that elevated NT-proBNP in our study was caused by cardiac failure. However, a majority of our subjects had a history of congestive heart failure and were treated with diuretics. We assume, therefore, that the raised NT-proBNP levels observed could have been caused by cardiac failure. We also found that our population had surprisingly high NT-proBNP levels, higher than that seen in previous studies. 13 21 This could be due to the fact that, apart from a history of congestive heart failure in many subjects, our subjects were very old (mean age: 85.6) and had serious comorbidity (ASA III and IV).
Several studies have established a dose-dependent correlation between increased BNP levels and left ventricular systolic dysfunction. 9 22 Elevated BNP has been shown to be more accurate than clinical examination in identifying patients with cardiac failure as a cause of dyspnoea in the emergency department. 9 The natriuretic peptides have also been shown to have an important prognostic value in predicting major adverse cardiac events in patients with heart failure and acute coronary syndrome. 12 19 23 In this study, we used perioperative cardiac events, as an outcome variable. This variable included patients who, in addition to a postoperative myocardial damage, could have had a TnI elevation before surgery. The choice of perioperative cardiac events as an outcome variable instead of strict postoperative events was made to give a more realistic perspective of the cardiac risk in this high-risk geriatric group of patients undergoing hip fracture surgery. Owing to the nature of our patient population, the high incidence of myocardial damage before surgery is not surprising. However, this would have been missed without perioperative TnI analysis, since no subjects had clinical symptoms of ongoing myocardial ischaemia before surgery. NT-proBNP elevation is, as mentioned earlier, a known predictor of poor outcome in patients with acute coronary syndrome, and myocardial ischaemia is one factor that may cause left ventricular systolic dysfunction and elevated NT-proBNP. This could explain the close correlation between elevated NT-proBNP before surgery and perioperative myocardial damage seen in this study. The usefulness of BNP and NT-proBNP as prognostic markers of outcome after elective surgery has been clearly established. 15 24 25 Results from these investigations suggest that both BNP and NT-proBNP are useful in predicting perioperative adverse outcome. In this study, we verified previous data showing a close correlation between preoperative elevated NT-proBNP and cardiac events in subjects undergoing non-elective surgery.
13 -15 24 We also showed that a history of congestive heart failure was an independent predictor of perioperative cardiac events after acute hip fracture surgery. Together with pneumonia, cardiac failure is the leading cause of in-hospital mortality after surgical correction of hip fractures. 26 27 Previous studies have found 30 days mortality of 10% after surgical correction of proximal femur fractures. 2 27 Despite the fact that our subjects were ASA class III or IV with serious comorbidity, the overall 30 day mortality rate in our present study was 12%, which is similar to the previous studies. 2 3 However, we did not see any significant differences in mortality between patients with NT-proBNP above and below 3984 ng litre
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. NT-proBNP has also been shown to be as reliable as preoperative dobutamine stress echocardiogram and the Revised Cardiac Risk Index in predicting major adverse cardiac events. 14 28 However, neither ASA classification nor the Revised Cardiac Risk Index could predict outcome in this patient population undergoing emergency surgery.
There are limitations to our study. This is a cohort from a larger study where 211 subjects undergoing emergency surgery were included, which means that our study group is rather small, albeit at high risk for morbidity and mortality. We assessed NT-proBNP before operation only and it is possible that many more patients may have developed laboratory evidence of left ventricular dysfunction after operation. In one study, it was found that a postoperative NT-proBNP level better predicts outcome than a preoperative level. 29 If we had also followed the course of NT-proBNP levels after operation, we might have found a better correlation between NT-proBNP and adverse cardiac events. Another limitation to our study is that we have no data on fluid management perioperatively. It would have been valuable to compare the amount of fluids given in relation to the NT-proBNP values and the occurrence of adverse cardiac events. Finally, the creatinine levels in subjects with elevated NT-proBNP were significantly higher than in those with NT-proBNP below the diagnostic threshold. This might have influenced our results since a high NT-proBNP in subjects with renal dysfunction is associated with a lower specificity in predicting major adverse cardiac events. 30 In conclusion, this study shows that elderly high-risk patients undergoing hip fracture surgery had a high incidence of elevated NT-proBNP before operation. An NT-proBNP level 3984 ng litre 21 was an independent predictor of perioperative adverse cardiac events in our group of subjects. The use of NT-proBNP as a routine test in high-risk patients undergoing emergency hip surgery could be a useful tool in assessing perioperative risk and an aid to clinical decisions on pre-and postoperative treatment and monitoring. Future studies should seek to identify the potential of using this test in other settings and in other groups of patients.
